NDC 80203-347

Enjaymo jome

Sutimlimab

Enjaymo jome is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Bioverativ U.s. Llc.. The primary component is Sutimlimab.

• Product ID: 80203-347_2c734092-5fa6-4e71-a23a-6a257108a4ab
• NDC: 80203-347
• Product Type: Human Prescription Drug
• Proprietary Name: Enjaymo jome
• Generic Name: Sutimlimab
• Dosage Form: Injection, Solution, Concentrate
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2022-02-04
• Marketing Category: BLA /
• Application Number: BLA761164
• Labeler Name: Bioverativ U.S. LLC.
• Substance Name: SUTIMLIMAB
• Active Ingredient Strength: 50 mg/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 80203-347-01

1 VIAL, SINGLE-DOSE in 1 CARTON (80203-347-01) > 22 mL in 1 VIAL, SINGLE-DOSE

• Marketing Start Date: 2022-02-04
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details